{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["27(1)"],"submitter":["Qiao Z"],"funding":["Young Pearl River Scholar of Guangdong Province, Chinese Medicine Guangdong Laboratory","Administration of Traditional Chinese Medicine of Guangdong Province","National Natural Science Foundation of China","Guangzhou Basic and Applied Basic Research Foundation","Characteristic Innovation Projects of Universities in Guangdong Province"],"journal":["Arthritis research & therapy"],"pagination":["167"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12366394"],"repository":["biostudies-literature"],"pubmed_title":["Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15/STAT3 signaling pathway."],"pmcid":["PMC12366394"],"funding_grant_id":["82074019","2025A04J5398","20222042","2023KTSCX023","HOL2024PZ042"],"pubmed_authors":["Su T","Meng Q","Long Y","Qiao Z","Xiao B","Liang Q"],"additional_accession":[]},"is_claimable":false,"name":"Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15/STAT3 signaling pathway.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Aug","modification":"2026-05-07T00:18:38.813Z","creation":"2026-04-07T22:20:19.388Z"},"accession":"S-EPMC12366394","cross_references":{"pubmed":["40835949"],"doi":["10.1186/s13075-025-03629-1"]}}